Search results
Warning letter: USFDA pulls up Sun Pharma for manufacturing issues at Dadra facility
The Economic Times· 6 days agoSun Pharma failed to adequately clean and maintain equipment used for drug manufacturing at its...
Warning letter: USFDA pulls up Sun Pharma for manufacturing issues at Dadra facility - ET...
The Economic Times· 6 days agoNew Delhi: Sun Pharma failed to adequately clean and maintain equipment used for drug manufacturing...
USFDA pulls up Sun Pharma over lack of cleanliness
Tribune India· 6 days agoSun Pharma failed to adequately clean and maintain equipment used for drug manufacturing at its Dadra-based manufacturing plant, as per the US Food and...
Dr Reddy's, Sun Pharma recall drugs in US market: USFDA
The Economic Times· 6 days agoDr Reddy's Laboratories and Sun Pharma are recalling products in the US due to manufacturing issues,...
Alembic Pharma receives USFDA nod for Bromfenac Ophthalmic Solution
Business Standard India· 15 hours agoVadodara-based generic drugmaker Alembic Pharmaceuticals on Tuesday announced that it has received...
Nifty Pharma up 48% in the last 1 year; Zydus, Lupin, Glenmark surge over 95% each; what is driving...
Livemint· 2 days agoThe Nifty Pharma index hit a fresh 52-week high of 20,575.35 in intraday trade on Monday, July 8....
Sun Pharma.Inds. Summary: Latest Updates and Details | India Infoline
India Infoline· 6 days agoSun Pharmaceutical Industries Limited including its subsidiaries and associates (Sun Pharma) is the fourth largest global specialty generic ...
Sun Pharma Advanced Research Company Ltd Stock Price: SPARC Share Price Today | India Infoline
India Infoline· 5 days agoSPARC Share Price: Get the live NSE/BSE stock price of Sun Pharma Advanced Research Company Ltd with performance, market cap, financial report, and company profile at India Infoline.
Dr Reddy's, Sun Pharma recall drugs in US market: USFDA
CNBC Awaaz· 6 days agoAccording to the report, Dr Reddy's Laboratories is recalling drugs to treat insomnia and gout in...
EMA validates Philogen and Sun Pharma’s MAA for melanoma
Pharmaceutical Technology· 5 days ago“Our group is committed to working with EMA throughout the review process to make Nidlegy available...